Wed, September 28, 2022
Tue, September 27, 2022
Mon, September 26, 2022
Fri, September 23, 2022
Thu, September 22, 2022
Wed, September 21, 2022
Tue, September 20, 2022
Mon, September 19, 2022
Fri, September 16, 2022
Thu, September 15, 2022

Robyn Karnauskas Maintained (BIIB) at Strong Buy with Decreased Target to $265 on, Sep 22nd, 2022

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. th-decreased-target-to-265-on-sep-22nd-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Robyn Karnauskas of Truist Securities, Maintained "Biogen Inc." (BIIB) at Strong Buy with Decreased Target from $270 to $265 on, Sep 22nd, 2022.

Robyn has made no other calls on BIIB in the last 4 months.



There are 5 other peers that have a rating on BIIB. Out of the 5 peers that are also analyzing BIIB, 2 agree with Robyn's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Paul Matteis of "Stifel" Maintained at Hold with Decreased Target to $223 on, Monday, September 12th, 2022
  • Carter Gould of "Barclays" Maintained at Hold with Decreased Target to $200 on, Thursday, July 21st, 2022


These are the ratings of the 3 analyists that currently disagree with Robyn


  • Phil Nadeau of "Cowen & Co." Maintained at Buy with Decreased Target to $270 on, Thursday, July 21st, 2022
  • Ami Fadia of "Needham" Maintained at Strong Buy with Decreased Target to $250 on, Thursday, July 21st, 2022
  • Jay Olson of "Oppenheimer" Maintained at Buy with Increased Target to $230 on, Monday, July 18th, 2022